AxioMed

AxioMed Spine was founded in 2001 to develop products aimed at restoring spinal function for patients with degenerative spinal diseases, thereby raising the standard of care beyond fusion and first-generation artificial intervertebral discs. Since its inception, AxioMed has secured over $34 million in private equity financing from prominent venture capitalists. The company’s Freedom® Lumbar Disc has been developed and entered clinical trials. Led by CEO Patrick McBrayer, who joined AxioMed in early 2006, the company is guided by an experienced management and development team, including founder and COO James Kuras. This team brings significant historical expertise in spinal implants, including early artificial disc development efforts. The professional staff includes experts with extensive experience in spine and engineering fields. The team has been further strengthened by a consulting group of surgeons from leading spine centers and universities. The company’s headquarters encompasses product development and testing, clinical and regulatory affairs, as well as manufacturing. AxioMed will leverage its background in lumbar disc replacement along with ongoing cervical development projects.